Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2
Article
[키워드] accelerate
acute respiratory syndrome
approach
approved
benefit
caused
cell membrane
Clinical use
coronavirus
Coronavirus disease 2019
COVID-19
death
demonstrated
dependent on
drug
effort
Endoplasmic reticulum
ERS pathway
Extensive
feasibility
globe
inhibitor
New
overcome
pathway
pharmacological
Potential
Protein
protein translation
regulatory agencies
Replication
resulting
SARS-CoV-2
SARS-COV-2 infection
secretory pathway
shown
suppress
targeting
the SARS-CoV-2
therapeutic option
unfolded protein response
virion
[DOI] 10.1016/j.virusres.2022.198897 PMC 바로가기
[DOI] 10.1016/j.virusres.2022.198897 PMC 바로가기